InMode Ltd. Stock Hits Day Low of $13.95 Amid Price Pressure

InMode Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced significant volatility today, with the stock hitting an intraday low of USD 13.95. The stock has declined by 8.15% on February 24, 2026, contrasting sharply with the S&P 500's modest gain of 0.69% for the day. Over the past week, InMode has seen a decrease of 2.24%, while its performance over the last month shows a slight increase of 0.22. However, the longer-term outlook remains challenging, with a notable decline of 26.03% over the past year and a staggering 61.13% drop over the last three years. Financial metrics indicate that InMode has faced difficulties, reporting a net profit of USD 27.03 million, which reflects a significant fall of 67.35%. The company's operating cash flow is at its lowest, recorded at USD 90.42 million, and its return on capital employed stands at 13.53%. With a market capitalization of USD 1,239 million, InMode continues to navigate a tough landscape in the biotechnology industry.